Posted on 7/6/16
New Jersey Health Care Quality Institute CEO Linda J. Schwimmer, JD, Shares Emerging Healthcare Trends with Samaritan Leaders
Linda J. Schwimmer, JD, New Jersey Health Care Quality Institute president/CEO, recently presented at the Laurel Creek Country Club in Mount Laurel, as part of Samaritan’s . . .
Posted on 7/6/16
Sharps Compliance Acquires Citiwaste
Sharps Compliance Corp. (NASDAQ:SMED), a leading full-service national provider of comprehensive waste management solutions including medical
Posted on 7/5/16
Medical Society of New Jersey Announces Prescription Assistance Program for Patients
Patients who need help with the cost of prescription medications can now obtain a free prescription assistance card provided by the state’s largest association of physicians.The . . .
Posted on 7/5/16
Better Buy: Celgene Corporation vs. Merck
Celgene Corp. (NASDAQ:CELG) and Merck (NYSE:MRK) are both top-flight biopharma stocks with significant footprints in the rapidly growing oncology market. But which is the better stock . . .
Posted on 7/5/16
Better Buy: GlaxoSmithKline plc vs. Merck
GLAXOSMITHKLINE IS RESEARCHING THE FIELD OF BIOELECTRONICS FOR POTENTIAL NEW ADVANCES. IMAGE SOURCE: GLAXOSMITHKLINE.Investors like pharmaceutical stocks because of the combination of dividend income and growth . . .
Posted on 7/4/16
Retro Fitness Named One of the Best Fitness Franchises by Forbes Magazine
COLTS NECK, N.J.--(BUSINESS WIRE)--Retro Fitness has once again been recognized by Forbes Magazine as one of the country’s best franchise investments with entry costs of $500,001 . . .
Posted on 7/1/16
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
The U.S. presidential election and the Brexit vote have combined to wreck havoc on biopharma stocks this year. On the bright side, these headwinds appear to . . .
Posted on 6/30/16
Iroko Pharmaceuticals Secures Debt Financing From CRG
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company has entered into a $140 million . . .
Posted on 6/29/16
Johnson & Johnson Shareholders: Knowing Your Smallest Segment
A casual observer would probably not expect that Consumer Products is the smallest segment of Johnson & Johnson (NYSE:JNJ). Its products blanket advertising streams with the . . .
Posted on 6/28/16
When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?
IMAGE SOURCE: GETTY IMAGES.It's been a rough year to be an investor in Gilead Sciences (NASDAQ:GILD), Celgene(NASDAQ:CELG), or CVS Health (NYSE:CVS). All three of these high-quality . . .
Posted on 6/28/16
Better Buy: Merck & Co. Inc. vs. AbbVie
IMAGE SOURCE: GETTY IMAGES.The pharmaceutical sector has been an extremely lucrative industry over time, allowing investors to profit from the development of treatments that have improved . . .
Posted on 6/28/16
Why Celator Pharmaceuticals Is Up 1,610% in 2016
IMAGE SOURCE: GETTY IMAGES.What: Shares of Celator Pharmaceuticals (NASDAQ:CPXX), a clinical-stage oncology-focused biopharmaceutical company, have rocketed 1,610% higher year to date, according to data from S&P . . .
Posted on 6/28/16
Teva and Antares Pharma Announce Launch of Generic Imitrex in the United States
JERUSALEM & EWING, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) and Antares Pharma, Inc. (NASDAQ:ATRS) today announced the launch of the generic equivalent to . . .
Posted on 6/28/16
GreenDrop Announces Partnership with the American Red Cross
BENSALEM, Pa.--(BUSINESS WIRE)--TodayGreenDrop, the organization transforming the way consumers donate lightly used clothing, electronics, and household goods, has added the American Red Crossto its roster of . . .
Posted on 6/27/16
inVentiv Health Selected By Pfizer As Preferred Provider For Global Clinical Services
inVentiv Health Inc., a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market, today announced that it . . .
Posted on 6/27/16
The Medicines Company Announces Positive Top- Line Results for Phase 3 TANGO 1 Clinical Trial of CARBAVANCE
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that its investigational antibiotic, CARBAVANCE (meropenem-vaborbactam), met both FDA and EMA pre-specified primary endpoints in the Phase 3 . . .
Posted on 6/27/16
Brexit Sell-Off Hits 3 Big Pharma Bargain Stocks
IMAGE SOURCE: GETTY IMAGES.With the British pound and the euro both sinking after Britain's vote to leave the EU, stock markets are in turmoil, and a . . .
Posted on 6/27/16
3 Biotech Stocks to Buy Now for the Long Haul
IMAGE SOURCE: FLICKR USER STOCKMONKEYS.COM.Patent expiration risk means that today's biotech leaders may not be the leaders of tomorrow, but despite that risk, Gilead Sciences (NASDAQ:GILD), . . .
Posted on 6/24/16
CloudMine Named Recipient of the 2016 SIIA CODiE Award for Best Information Service Delivered as Mobile App or Platform
CloudMine, healthcare’s secure data platform, was named Best Information Service Delivered as Mobile App or Platform of 2016 as part of the 2016 SIIA CODiE Awards.With . . .
Posted on 6/24/16
Better Buy: Biogen Inc. vs. Celgene Corporation
IMAGE SOURCE: GETTY IMAGES.The latest version of our ongoing better buy series pits two large biotechs -- Celgene(NASDAQ:CELG) and Biogen (NASDAQ:BIIB) -- against each other. In . . .
Posted on 6/22/16
Alliance Oncology Partners with Saint Peter’s University Hospital
NEWPORT BEACH, Calif. & NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Alliance Oncology, a division ofAlliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today . . .
Posted on 6/21/16
Medgenics Prices Stock Offering
Medgenics, Inc. (NYSE MKT: MDGN) today announced the pricing of 3,640,000 shares of its common stock in a previously announced underwritten public offering at a price . . .
Posted on 6/21/16
SCYNEXIS Prices $22.5 Million Stock Offering
JERSEY CITY, N.J., June 21, 2016 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of 9,375,000 shares of its . . .
Posted on 6/21/16
Why Achillion Pharmaceuticals Is Down Big in 2016
IMAGE SOURCE: ACHILLION PHARMACEUTICALS.What: Despite co-developer Johnson & Johnson (NYSE:JNJ) making progress on developing next-generation therapies for hepatitis C, shares in Achillion Pharmaceuticals(NASDAQ:ACHN) have tumbled 15.6% . . .
Posted on 6/21/16
SCYNEXIS Announces Launch of Public Offering of Common Stock and Warrants
JERSEY CITY, N.J., June 20, 2016 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has commenced an underwritten public offering of shares of its . . .
Philadelphia
